Cardio Diagnostics Holdings Inc（CDIO）のニュースとイベントCDIOCardio Diagnostics Holdings Inc

Cardio Diagnostics Partners with AHP to Cover Tests

Cardio Diagnostics Holdings announces that Atlas Healthcare Physicians, AHP, will cover Cardio Diagnostics' tests, Epi+Gen CHD and PrecisionCHD, for their members with prior authorization beginning May 2026.

Cardio Diagnostics Sets Final Payment Rate of $854 for Epi+Gen CHD and PrecisionCHD Tests

Cardio Diagnostics announced that the Centers for Medicare and Medicaid Services has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD and PrecisionCHD tests. This finalized rate represents an increase from the preliminary gapfill payment rates of $350 for Epi+Gen CHD and $684.76 for PrecisionCHD. Obtaining the final rate will be effective for claims with dates of service on or after January 1, 2026.

Cardio Diagnostics gets CMS gapfill payment rates for cardiovascular tests

Cardio Diagnostics announced that the Centers for Medicare and Medicaid Services, through the MolDX program, has issued preliminary gapfill payment rates of $350 for Epi+Gen CHD and $684.76 for PrecisionCHD. These preliminary rates, part of the 2025 gapfill pricing process, are expected to be finalized later this year and effective for claims on or after January 1, 2025. The company stated this is a critical step toward expanding access to its advanced cardiovascular testing for Medicare beneficiaries.